Challenges constraining availability and affordability of insulin in Bengaluru region (Karnataka, India): evidence from a mixed-methods study

References

• United Nations Sustainable development knowledge platform [Internet]. USA: Transforming our world: the 2030 agenda for sustainable development. Available from: https://sustainabledevelopment.un.org/post2015/transformingourworld. Accessed 01 May 2018.
   Google Scholar
• Global report on diabetes. Geneva: World Health Organisation; 2016. Available from: https://apps.who.int/iris/bitstream/handle/10665/204871/9789241565257_eng.pdf;jsessionid=A37F21ADE4FBD155168C78D928BA04FD?sequence=1. Accessed 22 May 2019.
   Google Scholar
• Laing R Waning B, Gray A, Ford N, Hoen E. 25 years of the WHO essential medicines lists: progress and challenges. Lancet. 2003;361:1723–1729.
   PubMed Web of Science ®Google Scholar
• Beran D, Ewen M, Laing R. Constraints and challenges in access to insulin: a global perspective. Lancet Diabetes Endocrinol. 2016;4(3):275–285.
   PubMed Web of Science ®Google Scholar
• Sharma A, Bhandari P, Neupane D, Kaplan WA, Mishra SR. Challenges constraining insulin access in Nepal- a country with no local insulin production. Int Health. 2018;10(3):182–190.
   PubMed Web of Science ®Google Scholar
• Liu C, Zhang X, Liu C, Ewen M, Zhang Z, Liu G. Insulin prices, availability and affordability: a cross- sectional of pharmacies in Hubei province, China. BMC Health Serv Res. 2017;17:597.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Surveying insulin availability and prices: vital to treating diabetes. Geneva: Essential medicines and health Products. Available from: https://www.who.int/medicines/areas/access/webstory_diabetes/en/. Accessed 01 May 2018.
   Google Scholar
• Health Action International [Internet]. Amsterdam: ACCISS Research. Available from: https://haiweb.org/what-we-do/acciss-reports/. Accessed 15 Aug 2019.
   Google Scholar
• Gill G, Yudkin J, Tesfaye S, Courten M, Gale E, Motala Aet al, Essential medicines and access to insulin. Lancet Diabetes Endocrinol. 2017;5:324–325.
   PubMed Web of Science ®Google Scholar
• Dandona L, Dandona R, Kumar GA, Shukla DK, Paul VK, Balakrishnan Ket al. Nations within a nation: variations in epidemiological transition across the states of India, 1990-2016 in the global burden of disease study. Lancet.. 2017;390:2437–2460.
   PubMed Web of Science ®Google Scholar
• WHO Essential Medicines and health products information portal [Internet]. India: National list of essential medicines; 2015. Available from: http://apps.who.int/medicinedocs/en/d/Js23088en/. Accessed 16 June 2018.
   Google Scholar
• La Forgia G, Nagpal SGovernment-sponsored health insurance in India: are you covered?. 2012Washington DCWorld Bank Publications10.1596/978-0-8213-9618-6.
   Google Scholar
• Ravi S, Ahluwalia R, Bergkvist SHealth and Morbidity in India (2004–2014). Brookings India. 2016 Research Paper No. 092016
   Google Scholar
• Chitra R. Online pharmacies are helping in lowering health costs in India. Economic Times [newspaper on Internet]. 2018. Available from: https://economictimes.indiatimes.com/small-biz/startups/newsbuzz/online-pharmacies-are-helping-to-lower-healthcare-costs-in-india/articleshow/66574813.cms?from=mdr. Accessed 29 July 2019.
   Google Scholar
• Government of India, Department of Pharmaceuticals. Jan Aushadhi. Delhi: Bureau of Pharma PSUs of India. Available from: http://janaushadhi.gov.in/. Accessed 19 Apr 2017.
   Google Scholar
• Singhal GL, Kotwani A, Arun N. Jan Aushadhi stores in India and quality of medicines therein. Int J Pharm Pharm Sci. 2011;3(1):204–7 Available from: https://pdfs.semanticscholar.org/306e/dad79e36bdfafed1b94dcaccfed4fcc6a5a9.pdf. Accessed 19 Aug 2019.
   Google Scholar
• Sharma A, Kaplan WA. Challenges constraining access to insulin in the private-sector market of Delhi, India. BMJ Glob Health. 2016;1:e000112.
   PubMedGoogle Scholar
• Faruqui Neha, Martiniuk Alexandra, Sharma Abhishek, Sharma Chanchal, Rathore Bhumika, Arora Ramandeep Singh, Joshi Rohina. Evaluating access to essential medicines for treating childhood cancers: a medicines availability, price and affordability study in New Delhi, India. BMJ Global Health. 2019;4(2):e001379.
   PubMed Web of Science ®Google Scholar
• Luo J, Avorn J, Kesselheim AS. Trends in Medicaid reimbursements for insulin from 1991 through 2014. JAMA Intern Med. 2015;175:1681–1687.
   PubMed Web of Science ®Google Scholar
• Karnataka State Drugs Logistics and Warehousing Society [Internet]. India; 2019. Available from: http://kdlws.kar.nic.in/docs/Essential_Drug_List.pdf. Accessed 21 Jan 2019.
   Google Scholar
• Holloway KA, Gupta M. Pharmaceuticals in Health Care Delivery. Mission Report 2013. Karnataka, India: World Health Organization Regional Office for South East Asia. Available from: http://www.searo.who.int/entity/medicines/karnataka_july_2014.pdf?ua=1.
   Google Scholar
• Lu CY, Emmerick IC, Stephens P, Ross-Degnan D, Wagner AK. Uptake of new antidiabetic medications in three emerging markets: a comparison between Brazil, China and Thailand. J Pharm Policy Pract. 2015;8(1):7.
   PubMedGoogle Scholar
• Mohan V, Shah SN, Joshi SR, Seshiah V, Sahay BK, Banerjee Set al. Current status of management, control, complications and psychosocial aspects of patients with diabetes in India- results from the DiabCare India 2011 study. Indian J Endocrinol Metab. 2014;18(3):370–378.
   PubMedGoogle Scholar
• Baruah MP, Kalra S, Bose S, Deka J. An audit of insulin usage and insulin injection practices in a large Indian cohort. Indian J Endocrinol Metab. 2017;21(3):443–452.
   PubMedGoogle Scholar
• Grunberger G. Insulin analogues- are they worth it? Yes!. Diabetes Care. 2014;37(6):1767–1770.
   PubMed Web of Science ®Google Scholar
• Davidson MB. Insulin analogues- is there a compelling case to use them? No!. Diabetes Care. 2014;37(6):1771–177410.2337/dc13-2915.
   PubMed Web of Science ®Google Scholar
• Hogerzeil H. Open session: health action international [Internet]. Geneva: In proceeding of the WHO 22nd Expert Committee on the Selection and Use of Essential Medicine; 2019. Available from: https://www.who.int/selection_medicines/committees/expert/22/HAI_Statement_OpenSession1April2019.pdf?ua=1. Accessed 22 May 2019.
   Google Scholar
• WHOThe selection and use of essential medicines: report of the WHO Expert Committee, March 2011 (including the 17th WHO Model List of Essential Medicines and the 3rd WHO Model List of Essential Medicines for children). 2011GenevaWorld Health Organization
   Google Scholar
• Beran D, Laing RO, Kaplan W, Knox R, Sharma A, Wirtz VJet al. A perspective on global access to insulin: a descriptive study of the market, trade flows and prices. Diabet Med. 2019;36(6):726–733.
   PubMed Web of Science ®Google Scholar
• Beran D, Hemmingsen B, Yudkin JS. Analogue insulin as an essential medicine: the need for more evidence and lower prices. Lancet Diabetes Endocrinol. 2019;7(5):P338.
   PubMed Web of Science ®Google Scholar
• Thawani V, Mani A, Upmanyu N. Why the Jan Aushadhi scheme has lost its steam in India?. J Pharmacol Pharmaother. 2017;8(3):134–136
   PubMed Web of Science ®Google Scholar
• Generics and Biosimilar Initiative [Internet]. USA: Jan Aushadhi and affordability and accessibility of medicines in India. Available from: http://www.gabionline.net/Generics/Research/Jan-Aushadhi-and-affordability-and-accessibility-of-medicines-in-India. Accessed 11 June 2018.
   Google Scholar
• Sharma A, Rorden L, Ewen M, Laing R. Evaluating availability and price of essential medicines in Boston area (Massachusetts, USA) using WHO/HAI methodology. J Pharm Policy Pract. 2016;9:12.
   PubMedGoogle Scholar
• Sharma A, Ladd E, Unnikrishnan MK. Healthcare inequity and physician scarcity: empowering non-physician healthcare. Econ Polit Wkly. 2013;48:112–117
   Google Scholar
• Kaplan WA, Wirtz VJ, Stephens P. The market dynamics of generic medicines in the private sector of 19 low and middle income countries between 2001 and 2011: a descriptive time series analysis. PLoS One. 2013;8(9):e74399.
   PubMed Web of Science ®Google Scholar
• Vayalil MP, Rajesh V, Rajan MS, Girish T. Online pharmacy regulation in India: a cross- sectional survey on perceptions of health care students/ professionals. Value Health. 2016;19(7):A816.
   Web of Science ®Google Scholar
• Raghavan P. Government may regulate e-Pharmacies soon. Economic Times [newspaper on internet]. 2016. Available from: https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/government-may-regulate-e-pharmacies-soon/articleshow/53386788.cms. Accessed 13 June 2018.
   Google Scholar
• Tieu C, Lucas EJ, DePaola M, Rosman L, Alexander GC. Efficacy and safety of biosimilar insulins compared to their reference products: a systematic review. PLoS One. 2015;13(4):e0195012.
   Google Scholar
• Biocon’s insulin Glargine receives regulatory approval in Japan [Internet]. 2016. Available from: https://www.biocon.com/docs/BioconFFP_Glargine_PR_28032016.pdf. Accessed 23 June 2018.
   Google Scholar
• BioPharm International [Internet]. Mylan and Biocon get approvals for biosimilar insulin Glargine in Europe and Australia. BioPharm International Editors. 2018. Available from: http://www.biopharminternational.com/mylan-and-biocon-get-approvals-biosimilar-insulin-glargine-europe-and-australia. Accessed 11 June 2018.
   Google Scholar
• Mukherjee R. Govt plans to allow chemists to suggest generic substitutes. Times of India [newspaper on internet]. 2017. Available from: https://timesofindia.indiatimes.com/india/govt-plans-to-allow-chemists-to-suggest-generic-substitutes/articleshow/62045423.cms. Accessed 23 June 2018.
   Google Scholar
• Baru R, Acharya A, Acharya S, Shivakumar AK, Nagaraj K. Inequities in access to health services in India: caste, class and religion. Econ Polit Wkly. 2010;45(38):49–58
   Google Scholar
• Sharma A, Kaplan WA, Chokshi M, Zodpey SP. Role of the private sector in vaccination service delivery in India: evidence from private-sector vaccine sales data, 2009–12. Health Policy Plan. 2016;31(7):884–896.
   PubMed Web of Science ®Google Scholar